Tokyo, Dec. 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060016) titled 'Research on the clinical outcomes of endoscopic retrograde cholangiopancreatography (ERCP)' on Dec. 8.
Study Type:
Observational
Primary Sponsor:
Institute - The Fraternity Memorial Hospital
Condition:
Condition - Pancreatobiliary diseases
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To examine the clinical outcomes of ERCP-related procedures and their prognostic factors.
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients who undergo ERCP for diagnostic and therapeutic indications
Key exclusion criteria - Patients with missing data on the main exposure variable of a given analysis and those who refused to participate in this research
Target Size - 8000
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2025 Year 12 Month 04 Day
Date of IRB - 2025 Year 12 Month 05 Day
Anticipated trial start date - 2025 Year 12 Month 05 Day
Last follow-up date - 2030 Year 11 Month 30 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068206
Disclaimer: Curated by HT Syndication.
